Ocular findings in Fabry's disease;Fabryjeva bolest i promjene na očima

Acta Medica Croatica

Volumn 60, Issue 2, 2006, Pages 163-166

  Kuzman, Tomislav ^a   Juri, Jelena ^a   Mrsić, Mirando ^a   Jeren Strujić, Branka ^b   Mandić, Zdravko ^c   Šikić, Jakov ^a  

^a KBC Zagreb   (Croatia)

^b University of Zagreb   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Cornea verticillata; Fabry's disease

Indexed keywords

AGALSIDASE BETA;

ADULT; ARTICLE; BIOMICROSCOPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; ENZYME REPLACEMENT; FABRY DISEASE; HEMANGIOKERATOMA; HUMAN; MALE; TREATMENT OUTCOME; ULTRASOUND; URINALYSIS; CORNEA DISEASE; EYE DISEASE; GENETICS; PEDIGREE;

ADULT; CORNEAL DISEASES; EYE DISEASES; FABRY DISEASE; HUMANS; MALE; PEDIGREE;

EID: 33748452879     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Desnick RJ, Ioannou YA, Eng CM. [alpha]-galactosidase A deficiency: Fabry disease. U: Schriver CR, Beaudet AL i sur, ur. The metabolic and molecular bases of inherited disease, Vol 2, 7th ed. New York: McGraw-Hill, 1995, 2741-84.
2. Masson C, Cisse I, Simon V, Insalaco P, Audran M. Fabry disease: a review. Joint Bone Spine 2004; 71: 381-3.
3. Crutchfield KE, Patronas Nj, Dambrosia JM. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 1998; 50: 1746-9.
4. Grewal RP. Stroke in Fabry's disease. J Neurol 1994; 241: 153-6.
5. Kono JO, Podskarbi T, Shin Y, Lanzl I. Oligosymptomatic cornea verticillata in a heterozygote for Fabry disease: a novel mutation in the alpha-galactosidase gene. Cornea 2003; 22: 175-7.
6. Kenyon KR, Chaves HV. Morphology and pathologic response of corneal and conjunctival disease. U: Smolin G, Thoft RA, ur. The cornea, 3rd ed. New York: Little, Brown and Company, 1994, 69-111.
7. Hirano K, Murata K, Miyagawa A i sur. Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry's disease. Cornea 2001; 20: 233-6.
8. Font RL, Fine BS. Ocular pathology in Fabry's disease. Histochemical and electron microscopical observations. Am J Ophthalmol 1972; 73: 419-30.
9. Fumex-Boizard L, Cochat P, Fouilhoux A, Guffon N, Denis P. Relation between ocular manifestations and organ involvement in ten patients with Fabry disease. J Fr Ophthalmol 2005; 28: 45-50.
10. Lou HOC, Heidensleben E, Larsen H-W. The value of ocular findings in the diagnosis of angiokeratoma corporis diffusum (Fabry's disease). Acta Ophthalmol 1970; 48: 1185-94.
11. De Schoenmakere G, Chauveau D, Grunfeld JP. Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function. Nephrol Dial Transplant 2003; 18: 33-5.
12. Wilcox WR, Banikazemi M, Guffon N i sur. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet 2004; 75: 65-74.
13. Konrad G, Kohlschutter A, Aust W. Significance of early ophthalmologic detection of Fabry disease. Klin Monatsbl Augenheilkd 1984; 185: 535-8.
14. Orssaud C, Dufier J, Germain D. Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients. Ophthalmic Genet 2003; 24: 129-39.
15. Hauser AC, Lorenz M, Voigtlander T, Fodinger M, Sunder-Plassmann G. Results of an ophthalmologic screening programme for identification of cases with Anderson-Fabry disease. Ophthalmologica 2004; 218: 207-9.